Australia Stock Exchange release from BCAL DIAGNOSTICS : Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test
02/11/2021 21:22
Australia Stock Exchange release from BCAL DIAGNOSTICS BDX.AX : Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test
Recent news on BCAL Diagnostics
See all newsAustralia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures